Crealta Holdings LLC

On Monday, Brean Capital issued a company update on Horizon Pharma PLC (NASDAQ: HZNP) after the pharmaceutical company announced the acquisition of Crealta Holdings LLC. Currently, Brean rates Horizon as a Buy and raised their price target from $31 to $32. Difei Yang, an analyst at Brean Capital,...